Approval · Notice of Compliance 1883 · 1999
PREVACID: Notice of Compliance 1883
Issued August 13, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1883
- Date
- August 13, 1999
- Company
- Tap Pharmaceuticals, Inc.Lake Forest, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: gastroesophageal reflux disease (gerd), treatment of heartburn and other symptoms associated with gerd
- Therapeutic class
- H+,k+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREVACID | Not yet assigned | — |
Medicinal ingredients
- LANSOPRAZOLE 15 MG per CAP
- LANSOPRAZOLE 30 MG per CAP